Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cegedim Dendrite Launches Innovative COUNTERxFEIT DETECT Program.


Groundbreaking Program Will Assist Pharmaceutical Companies with Anti-Counterfeiting Strategies

BEDMINSTER, N.J. -- Cegedim Dendrite dendrite: see nervous system; synapse.  today announced the launch of COUNTERxFEIT DETECT, a new offering that will assist pharmaceutical companies in identifying counterfeit product and determining where it entered their United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  supply chains. Cegedim Dendrite is the leading provider of compliance technology solutions and services in the pharmaceutical industry.

Counterfeit medicines represent a significant public health and safety issue for consumers. It also poses serious business and financial risks for manufacturers, including possible liability issues, lost revenue, erosion of brand confidence and negative public perception.

COUNTERxFEIT DETECT is designed for pharmaceutical companies that need to identify and determine the source of counterfeit, contaminated contaminated,
v 1. made radioactive by the addition of small quantities of radioactive material.
2. made contaminated by adding infective or radiographic materials.
3. an infective surface or object.
 or adulterated a·dul·ter·ate  
tr.v. a·dul·ter·at·ed, a·dul·ter·at·ing, a·dul·ter·ates
To make impure by adding extraneous, improper, or inferior ingredients.

adj.
1. Spurious; adulterated.

2. Adulterous.
 product. Cegedim Dendrite facilitates this by coordinating the purchase of non-controlled, finished drug products from contract manufacturers or distributors, using an independent pharmaceutical buyer. The product is shipped to a testing facility or the pharmaceutical company's analytical lab, where the product is analyzed.

"Drug counterfeiting is a concern in the pharmaceutical industry with estimates indicating that upward of more than; above.

See also: Upward
 8% of pharmaceutical medicines worldwide may be counterfeit," explained Bill Buzzeo, Cegedim Dendrite Vice President and General Manager, Compliance Solutions and OneKey. "As part of their anti-counterfeiting programs, pharmaceutical companies should acquire finished drug products within the supply chain for analysis and testing to ensure their quality. We seamlessly facilitate that process, and as far as we know, we're the only company that offers this type of program."

Cegedim Dendrite's independent purchasing of finished drug product takes the burden off the pharmaceutical company's internal resources. COUNTERxFEIT DETECT is fully secure and includes appropriate audit trail documentation that provides insight into the full acquisition chain associated with the independent pharmacy's purchase. "If an independent party is making the purchase," said Buzzeo, "the pharmaceutical company can better show that they had a random sample for testing and that the process was not tainted taint  
v. taint·ed, taint·ing, taints

v.tr.
1. To affect with or as if with a disease.

2. To affect with decay or putrefaction; spoil. See Synonyms at contaminate.

3.
 by anyone internally with false motive."

Cegedim Dendrite has been providing comprehensive compliance solutions to a broad range of pharmacy clients for 20 years. The company employs former state and federal regulators whose firsthand experience with compliance, fraud and abuse issues enable them to develop real-world prevention programs.

About Cegedim Dendrite:

Cegedim Dendrite is the life sciences industry's leading provider of Customer Relationship Management (CRM (Customer Relationship Management) An integrated information system that is used to plan, schedule and control the presales and postsales activities in an organization. ) solutions. Pharmaceutical by design, the company's innovative business solutions and global reach incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Dendrite enables more than 200,000 users in many of the world's top companies to stay ahead of market challenges. Cegedim Dendrite also provides sales, marketing and regulatory compliance solutions in more than 80 countries.

Cegedim Dendrite is part of the France-based Cegedim S.A. Group.

To learn more, please visit www.cegedimdendrite.com.

About Cegedim:

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, pharmaceutical companies, healthcare professionals and insurance companies. The world leader in pharmaceutical CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs 8,200 people in more than 80 countries and generated revenue of [euro]849 million in 2008. To learn more, please visit our website: www.cegedim.com

Listed on NYSE Euronext For other uses of "NYX", see NYX (disambiguation).

NYSE Euronext, Inc. (NYSE: NYX, Euronext: NYX) (formerly NYSE Group, Inc.) is a for-profit corporation that operates multiple securities exchanges, most notably the New York Stock Exchange (the "Big Board"),
 Paris, compartment B - ISIN Isin (ĭs`ĭn), capital of an ancient Semitic kingdom of N Babylonia. The city became important after the third dynasty of Ur fell to the Elamites and the Amorites (c.2025 B.C.). The phase from c.2025–c.1763 B.C.  FR0000053506 - Reuters CGDM CGDM Consortium on Green Design and Manufacturing .PA - Bloomberg CGM (1) (Computer Graphics Metafile) An ISO/IEC standard format for 2D graphics images introduced in 1987. Primarily a vector graphics format for technical illustrations and geophysical visualizations, CGM also supports raster graphics and text.  
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Company overview
Date:Jun 10, 2009
Words:564
Previous Article:Pzena Investment Management, Inc. Announces May 31, 2009 Assets Under Management.
Next Article:Shareholders Elect Tang Capital and Perceptive Nominees and Approve Shareholder Resolution.
Topics:

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles